Cargando…
LncRNA model predicts liver cancer drug resistance and validate in vitro experiments
Introduction: Hepatocellular carcinoma (HCC) patients may benefit from chemotherapy, but drug resistance is an important obstacle to favorable prognoses. Overcoming drug resistance is an urgent problem to be solved. Methods: Differential expression analysis was used to identify long non-coding RNAs...
Autores principales: | Yin, Qiushi, Huang, Xiaolong, Yang, Qiuxi, Lin, Shibu, Song, Qifeng, Fan, Weiqiang, Li, Wang, Li, Zhongyi, Gao, Lianghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106610/ https://www.ncbi.nlm.nih.gov/pubmed/37077416 http://dx.doi.org/10.3389/fcell.2023.1174183 |
Ejemplares similares
-
Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma
por: Wang, Yiru, et al.
Publicado: (2022) -
Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer
por: Yin, Qiushi, et al.
Publicado: (2023) -
Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
por: Ding, Hongmei, et al.
Publicado: (2022) -
LncRNA and its role in gastric cancer immunotherapy
por: Zhang, Qiang, et al.
Publicado: (2023) -
Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)